Apathy in first episode psychosis patients: A ten year longitudinal follow-up study

Schizophrenia Research

Volumn 136, Issue 1-3, 2012, Pages 19-24

  Evensen, Julie ^a,b   Røssberg, Jan Ivar ^a   Barder, Helene ^a   Haahr, Ulrik ^h   Hegelstad, Wenche ten Velden ^c   Joa, Inge ^c   Johannessen, Jan Olav ^c,f   Larsen, T K ^c,d   Melle, Ingrid ^a   Opjordsmoen, Stein ^a   Rund, Bjørn Rishovd ^b   Simonsen, Erik ^g   Sundet, Kjetil ^a,b   Vaglum, Per ^b   Friis, Svein ^a   McGlashan, Thomas ^e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF STAVANGER   (Norway)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

^h Early Psychosis Intervention Center   (Denmark)

Author keywords

Apathy; First episode psychosis; Negative symptoms; Outcome

Indexed keywords

ADULT; APATHY; ARTICLE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; QUALITY OF LIFE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; APATHY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF REPORT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84857999492     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.12.019     Document Type: Article

References (50)

1. Addington D., Addington J., Maticka-Tundale E., Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr. Res. 1992, 6(3):201-208.
2. Andersson S., Krogstad J.M., Finset A. Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reaction. Psychol. Med. 1999, 29(2):447-456.
3. Barch D.M. Emotion, motivation, and reward processing in schizophrenia spectrum disorders: what we know and where we need to go. Schizophr. Bull. 2008, 34(4):816-818.
4. Barone P., Antonini A., Colosimo C., Marconi R., Morgante L., Avarello T.P., Bottacchi E., Cannas A., Ceravolo G., Ceravolo R., Cicarelli G., Gaglio R.M., Giglia R.M., Iemolo F., Manfredi M., Meco G., Nicoletti A., Pederzoli M., Petrone A., Pisani A., Pontieri F.E., Quatrale R., Ramat S., Scala R., Volpe G., Zappulla S., Bentivoglio A.R., Stocchi F., Trianni G., Dotto P.D. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov. Disord. 2009, 24(11):1641-1649.
5. Benito-León J., Cubo E., Coronell C. Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: the ANIMO study. Mov. Disord. 2011, 10.1002/mds.23872.
6. Bentsen H., Munkvold O.G., Notland T.H., Boye B., Bjoerge H., Lersbryggen A.B., Oskarsson K.H., Berg-Larsen R., Malt U.F. The interrater reliability of the Positive and Negative Syndrome Scale (PANSS). Int. J. Methods Psychiatr. Res. 1996, 6:227-235.
7. Berman A.H., Bergman H., Palmstierna T., Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur. Addict. Res. 2005, 11(1):22-31.
8. Bleuler E. Dementia Praecox or the Group of Schizophrenias 1950, International Universities Press, New York.
9. Browne S., Clarke M., Gervin M., Waddington J.L., Larkin C., O'Callaghan E. Determinants of quality of life at first presentation with schizophrenia. Br. J. Psychiatry 2000, 176:173-176.
10. Clarke D.E., Van Reekum R., Patel J., Simard M., Gomez E., Streiner D.L. An appraisal of the psychometric properties of the Clinician version of the Apathy Evaluation Scale (AES-C). Int. J. Methods Psychiatr. Res. 2007, 16(2):97-110.
11. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 1976, 33:766-771.
12. Faerden A., Nesvag R., Barrett E.A., Agartz I., Finset A., Friis S., Rossberg J.I., Melle I. Assessing apathy: the use of the apathy evaluation scale in first episode psychosis. Eur. Psychiatry 2008, 23(1):33-39.
13. Faerden A., Vaskinn A., Finset A., Agartz I., Barrett E.A., Friis S., Simonsen C., Andreassen O.A., Melle I. Apathy is associated with executive functioning in first episode psychosis. BMC Psychiatry 2009, 9:1.
14. Faerden A., Friis S., Agartz I., Barrett E.A., Nesvag R., Finset A., Melle I. Apathy and functioning in first episode psychosis. Psychiatr. Serv. 2009, 60(11):1495-1503.
15. Faerden A., Finset A., Friis S., Agartz I., Barrett E.A., Nesvåg R., Andreassen O.A., Marder S.R., Melle I. Apathy in first episode psychosis patients: one year follow up. Schizophr. Res. 2010, 116(1):20-26.
16. Foussias G., Remington G. Negative symptoms in schizophrenia. Avolition and Occam's Razor. Schizophr. Bull. 2010, 36(2):359-369.
17. Foussias G., Mann S., Zakzanis K.K., van Reekum R., Remington G. Motivational deficits as the central link to functioning in schizophrenia: a pilot study. Schizophr. Res. 2009, 115(2-3):333-337.
18. Friis S., Larsen T.K., Melle I., Opjordsmoen S., Johannessen J.O., Haahr U., Simonsen E., Rund B.R., Vaglum P., McGlashan T. Methodological pitfalls in early detection studies - the NAPE Lecture 2002. Nordic Association for Psychiatric Epidemiology. Acta Psychiatr. Scand. 2003, 107:3-9.
19. Ho B.C., Nopoulos P., Flaum M., Arndt S., Andreasen N.C. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am. J. Psychiatry 1998, 155(9):1196-1201.
20. Karttunen K., Karppi P., Hiltunen A., Vanhanen M., Välimäki T., Martikainen J., Valtonen H., Sivenius J., Soininen H., Hartikainen S., Suhonen J., Pirttilä T. Int. J. Geriatr. Psychiatry 2010, 26:473-482. for the ALSOVA study group.
21. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
22. Kiang M., Christensen B.K., Remington G., Kapur S. Apathy in schizophrenia: clinical correlates and association with functional outcome. Schizophr. Res. 2003, 63(1-2):79-88.
23. Kimhy D., Yale S., Goetz R.R., McFarr L.M., Malaspina D. The factorial structure of the schedule for the deficit syndrome in schizophrenia. Schizophr. Bull. 2006, 32(2):274-278.
24. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 2006, 32:214-219.
25. Kraepelin E. Dementia Praecox and Paraphrenia, Reprint 1919 English Translated Edition 1919, Robert E. Krieger Publishing Co Inc., Huntington, New York.
26. Larsen T.K., McGlashan T.H., Johannessen J.O., Friis S., Guldberg C., Haahr U., Horneland M., Melle I., Moe L.C., Opjordsmoen S., Simonsen E., Vaglum P. Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. Am. J. Psychiatry 2001, 158:1917-1919.
27. Lehman A.F. A quality of life interview for the chronically mentally ill. Eval. Programme Plann. 1988, 11:51-62.
28. Lysaker P.H., Davis L.W. Social function in schizophrenia and schizoaffective disorder: associations with personality, symptoms, and neurocognition. Health Qual. Life Outcomes 2004, 2:15.
29. Malla A.K., Takhar J.J., Norman R.M., Manchanda R., Cortese L., Haricharan R., Verdi M., Ahmed R. Negative symptoms in first episode non-affective psychosis. Acta Psychiatr. Scand. 2002, 105(6):431-439.
30. Marin R.S. Apathy: a neuropsychiatric syndrome. J. Neuropsychiatry Clin. Neurosci. 1991, 3(3):243-254.
31. Marin R.S., Biedrzycki R.C., Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991, 38(2):143-162.
32. McPherson S., Fairbanks L., Tiken S., Cummings J.L., Back-Madruga C. Apathy and executive function in Alzheimer's disease. J. Int. Neuropsychol. Soc. 2002, 8(3):373-381.
33. Melle I., Larsen T.K., Haahr U., Friis S., Johannessen J.O., Opjordsmoen S., Simonsen E., Rund B.R., Vaglum P., McGlashan T.H. Reducing the duration of untreated first-episode psychosis. Arch. Gen. Psychiatry 2004, 61(2):143-150.
34. Melle I., Friis S., Haahr U., Johannesen J.O., Larsen T.K., Opjordsmoen S., Roessberg J.I., Rund B.R., Simonsen E., Vaglum P., McGlashan T. Measuring quality of life in first-episode psychosis. Eur. Psychiatry 2005, 20(7):474-483.
35. Messinger J.W., Trémeau F., Antonius D., Mendelsohn E., Prudent V., Stanford A.D., Malaspina D. Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clin. Psychol. Rev. 2011, 31(1):161-168.
36. Pedersen G., Hagtvet K.A., Karterud S. Generalizability studies of the global assessment of functioning-split version. Compr. Psychiatry 2007, 48(1):88-94.
37. Pluck G.C., Brown R.G. Apathy in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2002, 73(6):636-642.
38. Roth R.M., Flashman L., Saykin A., Thomas T.W., McAllister W., Vidaver R. Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits. Am. J. Psychiatry 2004, 161(1):157-159.
39. Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993, 88(6):791-804.
40. Selten J.P., Wiersma D., van den Bosch R.J. Distress attributed to negative symptoms in schizophrenia. Schizophr. Bull. 2000, 26(3):737-744.
41. Spitzer R.L., Williams J.B., Gibbon M., First M.B. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch. Gen. Psychiatry 1992, 49(8):624-629.
42. Starkstein S.E., Jorge R., Mizrahi R., Robinson R.G. A prospective longitudinal study of apathy in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2006, 77(1):8-11.
43. Starkstein S.E., Merello M., Brockman S., Bruce D., Petracca G., Power B.D. Apathy predicts more severe Parkinsonism in Alzheimer's disease. Am. J. Geriatr. Psychiatry 2009, 17(4):291-298.
44. Strauss J.S., Carpenter W.T. The prediction of outcome in schizophrenia II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Arch. Gen. Psychiatry 1974, 31(1):37-42.
45. Stuss D.T., Knight R.T. Principles of Frontal Lobe Function 2002, Oxford University Press, New York.
46. Tekin S., Cummings J.L. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J. Psychosom. Res. 2002, 53(2):647-654.
47. Tsoi T., Baillon S., Lindesay J. Early frontal executive impairment as a predictor of subsequent behavior disturbance in dementia. Am. J. Geriatr. Psychiatry 2008, 16(2):102-108.
48. Wegener S., Redoblado-Hodge M.A., Lucas S., Fitzgerald D., Harris A., Brennan J. Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Aust. N. Z. J. Psychiatry 2005, 39(6):487-492.
49. White C., Stirling J., Hopkins R., Morris J., Montague L., Tantam D., Lewis S. Predictors of 10-year outcome of first-episode psychosis. Psychol. Med. 2009, 39(9):1447-1456.
50. WHO Colloborating Centre for Drug Statistics Methodology 2008, ATC Index with DDDs.